Page last updated: 2024-09-03

mci 154 and Ventricular Dysfunction, Left

mci 154 has been researched along with Ventricular Dysfunction, Left in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hata, K; Hayashi, Y; Mori, M; Takaoka, H; Takeuchi, M; Yamaguchi, K; Yamakawa, H; Yokoyama, M1
Chen, HS; Hu, DY; Liu, LM; Lu, RQ; Ming, MJ; Nan, X1

Other Studies

2 other study(ies) available for mci 154 and Ventricular Dysfunction, Left

ArticleYear
Beneficial effects of a Ca2+ sensitizer, MCI-154, on the myocardial oxygen consumption-cardiac output relation in patients with left ventricular dysfunction after myocardial infarction: comparison with dobutamine and phosphodiesterase inhibitor.
    American heart journal, 1997, Volume: 133, Issue:3

    Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Hemodynamics; Humans; Imidazoles; Myocardial Infarction; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Ventricular Dysfunction, Left

1997
Effects of MCI-154, a calcium sensitizer, on cardiac dysfunction in endotoxic shock in rabbits.
    Shock (Augusta, Ga.), 2000, Volume: 13, Issue:6

    Topics: Animals; Calcium; Drug Evaluation, Preclinical; Female; Heart Diseases; Heart Function Tests; Hemodynamics; Lipopolysaccharides; Male; Myocardial Contraction; Pilot Projects; Pyridazines; Rabbits; Shock, Septic; Ventricular Dysfunction, Left; Ventricular Function, Left

2000